Cash for Colonoscopies: Colorado Tries to Lower Health Costs Through Incentives
State employees could receive checks ranging from $50 to thousands of dollars if they choose the right provider.
The independent source for health policy research, polling, and news.
61 - 80 of 352 Results
State employees could receive checks ranging from $50 to thousands of dollars if they choose the right provider.
UnitedHealth Group is the largest health insurer in the United States. And it keeps growing. This has led some health care experts to call for antitrust regulation of this “behemoth” company.
What do you do when a medical provider asks you to provide a credit card upfront? In this episode, we hear advice about your options in this situation.
An examination of billing policies and practices at more than 500 hospitals across the country shows widespread reliance on aggressive collection tactics.
Interviews with dozens of Kaiser Permanente therapists, patients and industry experts reveal superficial changes that look good on paper but do not translate into more effective and accessible care.
Michael Hunn left the clergy and became a hospital and health system executive. He’s been named CEO of CalOptima, Orange County’s Medi-Cal health insurance plan for low-income residents, and his spiritual background is helping him guide the publicly run plan into the future.
What should you do when your search for an in-network mental health care provider comes up empty? Abigail Burman has some expertise to share.
One listener tried to dispute a $1,300 “facility fee” with the treating hospital, his insurer, a bill-mediation service provided by his employer, and finally a debt collector. He didn’t win, but he learned valuable lessons about advocating for hospital discounts.
Hospital-acquired pneumonia not tied to ventilators is one of the most common infections that strike within health care facilities. But few hospitals take steps to prevent it, which can be as simple as dutifully brushing patients’ teeth.
KHN gives readers a chance to comment on a recent batch of stories.
Sensing that Republicans are walking into a political minefield by threatening once again to repeal the Affordable Care Act, the Biden administration is looking to capitalize by rolling out a series of initiatives aimed at high drug prices and other consequences of “corporate greed in health care.” Meanwhile, the Supreme Court hears a case that could determine when and how much victims of the opioid crisis can collect from Purdue Pharma, the drug company that lied about how addictive its drug, OxyContin, really was. Alice Miranda Ollstein of Politico, Anna Edney of Bloomberg News, and Rachana Pradhan of KFF Health News join KFF Health News chief Washington correspondent Julie Rovner to discuss these issues and more. Also this week, Rovner interviews Dan Weissmann of KFF Health News’ sister podcast, “An Arm and a Leg,” about his investigation into hospitals suing their patients over unpaid bills.
In California, health insurers blame long waits for therapy appointments on workforce shortages, but state lawmakers say that’s an excuse. A new law requires insurers to reduce wait times for mental health appointments to no more than 10 business days.
Lisa French was told her surgery would cost $1,337. But the hospital sent her a bill for $229,000, then sued her. The case went all the way to the Colorado Supreme Court. The court’s ruling could have major implications for determining a “reasonable price” in health care.
In carrying out the federal covid-19 “test-to-treat” initiative, California is targeting the uninsured by outfitting 138 testing sites with screenings for free antiviral drugs. But as of mid-June, fewer than 800 people had been prescribed the medicines. And two-thirds of those undergoing screenings are insured.
The law doesn’t take effect until July, but its passage should force insurers to expand their rosters of therapists. Here’s how you can challenge your health plan’s mental health services until then.
In tough labor negotiations across the nation, here's what nurses don’t want: “appreciation that is lip service,” “marketing campaigns” and “shiny new buildings.” And this year might well prove to be a turning point in efforts to organize health care’s essential workers.
Many of the 14 million patients in Medi-Cal are in managed care health plans that outsource their care to subcontractors or sub-subcontractors. For patients with difficult health care needs, it can be hard to know where to turn.
Patients sickened in heat waves, flooding and wildfire have raised awareness of climate change’s impact on health. Now, some hospitals are building solar panels and cutting waste to reduce their own carbon footprints, with support from a new office at the U.S. Department of Health and Human Services. But the industry is moving slowly.
Reports of waning effectiveness and mixed messages about booster shots fuel the politicization of vaccination.
The legality and availability of the abortion pill mifepristone is in question after a federal judge in Texas canceled the FDA’s approval of the first drug used in the two-drug medication abortion regimen. A 5th Circuit Court of Appeals panel overruled that decision in part, saying the pill should remain available, but only under the onerous restrictions in place before 2016. Meanwhile, another federal judge in Washington state issued a ruling in a separate case that conflicts with the Texas decision, ordering the FDA not to roll back any of its restrictions on the drug. Victoria Knight of Axios, Shefali Luthra of The 19th, and Sarah Karlin-Smith of the Pink Sheet join KFF Health News chief Washington correspondent Julie Rovner to discuss these issues and more.
© 2026 KFF